La Pharma S.r.l

[Martta]

Underour management philosophy of "the Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies", and as a Japan-based Global Specialty Pharmaceutical Company, we are striving to utilize diverse drug discovery technologies, such as our unique antibody technologies, to discover innovative new drugs that will make patients and their caregivers smile.

Moreover, the world is currently facing a number of issues, such as threats from climate change, damage to biodiversity, a lack of energy security and various types of inequality. We at Kyowa Kirin believe we should respond to these issues by taking actions based around SDGs (Sustainable Development Goals). Through our pharmaceuticals business, we will contribute to improving the lives of people suffering from disease and address the issues facing the world.

Whilst we continue to find new ways to treat, prevent, and ultimately find a cure for HIV, we are also focusing on understanding how we can bridge the gap between research and everyday clinical practice through implementation science and patient centred studies.

Our Media centre contains a range of resources including our latest and archived press releases and news updates, conferences and events we attend, our image and video library and social media information.

The process of identifying, creating and developing generally well-tolerated and effective innovative HIV therapies is complex and requires ongoing collaboration between research teams that work in many different areas of medicines development.

At ViiV Healthcare, we are on a mission to ensure that no person living with HIV is left behind. One of the ways we do this is by working actively with communities affected by HIV and AIDS around the world.

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link By reporting side effects, you can help provide more information on the safety of this medicine.

You are about to leave a ViiV Healthcare website. By clicking this link, you will be taken to a website that is independent from ViiV Healthcare. The site you are linking to is not controlled or endorsed by ViiV Healthcare and ViiV Healthcare is not responsible for the content provided on that site.

This is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, safety data or efficacy data for ViiV Healthcare products and/or their uses. Please refer to your nationally approved label or summary of product characteristics for up-to-date product information.

At CMP Pharma, we address the critical needs of older and younger patient populations through the development and manufacturing of a portfolio of high value semi-solid and liquid products. Our products include leading high-quality branded and generic prescription products, as well as a variety of non-prescription pharmaceutical products, which we distribute to hospitals, long-term care facilities, and retail channels.

CMP Pharma is a specialty pharmaceutical company that develops and manufactures a portfolio of high value topical and liquid products that address critical needs for niche markets within the pharmaceutical and life science industries.

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need.

Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

We are a medium-size pharmaceutical company with an entrepreneurial spirit. As such, we promote change and encourage the development of new ideas. We create opportunities for personal and professional development.

You may unsubscribe at any time using the link in communication received. Should you wish Curium to stop using your personal data, please contact the data responsible person through the following email address: complian...@curiumpharma.com.

We use Brevo as our marketing platform. By clicking below to submit this form, you acknowledge that the information you provided will be transferred to Brevo for processing in accordance with their terms of use.

Our diverse suite of industry-leading products is trusted by partners in over 60 countries. Our global office network covers from Paris, Berlin, to Istanbul, and New Delhi to St. Louis. Through continual innovation and expansion, we enable medical facilities across the world to deliver better quality care to their patients.

We know the paramount importance of reliably delivering our nuclear medicine products to our customers, while maintaining the highest standards of safety and quality control at every stage. At Curium, this is our priority.

Across our diverse and constantly-expanding portfolio, our state-of-the-art products include generators, cold kits, hot products and auxiliary products used in the diagnosis and treatment of a wide range of diseases.

Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses.

A fully integrated pharma company, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues. Aurobindo exports to over 150 countries across the globe with more than 90% of its revenues derived from international operations.

FPS is an Italian company specialized in the design and manufacture of containment systems and milling & micronization solutions for the handling and production of active and sterile pharmaceutical ingredients; it is mainly addressed to pharmaceutical, chemical and cosmetic companies all over the world.

With numerous innovative products for the treatment of skin, Merz Aesthetics is one of the leaders in asthetic medicine. A broad and well-coordinated portfolio of minimally invasive and non-invasive skin rejuvenation measures ensures that the needs and wishes of each patient can be individually addressed during treatment.

110 years ago, on March 9, 1918, the pharmacist and chemist Friedrich Merz founded the Chemische Fabrik Merz & Co. in Frankfurt am Main, Germany. Today, Merz remains a family-owned company, but has evolved into a global leader in aesthetic medicine and neurotoxin therapy.

Please note that if you submit information to Merz all materials submitted by electronic or physical communication will be deemed non-confidential. Do not submit any information or other materials that you consider to be confidential or proprietary. While we have no intention to publicly disclose any details of your proposal, we may refer to select experts within or outside the Merz network for evaluation.

3a8082e126